Cancer Causes, Screening and Diagnosis
A section of Cancers (ISSN 2072-6694).
Section Information
The future of cancerology, considering environmental pollution and technological advancements in cancer screening and diagnosis, is dependent on our efforts today toward better identifying the causes of cancer, improving screening and, also, the establishment and use of new diagnostic tests.
The section “Cancer Causes, Screening and Diagnosis” should provide essential data for the identification of carcinogens linked to physical, chemical, and biological causes as well as social, mental, and behavioral origins by exploration of the responsible molecules.
The physiological and genetic impacts in relation to the occurrence of cancer will be determined. Modern methods in medical imaging and personalized screening could thus help guide clinical decision-making.
This section will promote the rapid publication of contributions on all aspects of the causes of cancer. We encourage the submission of manuscripts that will assess the “physical, chemical, biological, and social” environmental impacts in oncology, and also all methodologies for cancer screening and diagnosis. Systematic reviews and articles relating to significant progress in this area will be included.
➢ Cancer causesMicroenvironments
- Chemical cancerogenesis
- Physical cancerogenesis
- Irradiation
- Biological cancerogenesis
- Viruses and their pathways
- Bacteria and their pathway
- miRNA axis
- Circular RNA axis
- Social impact
- Habit courants
- Behavioral impact
- Biopsies, cytology
- Cancer-associated antigens
- Circulating DNA and RNA/oligos
- Viral infection
- Bacterial infection
- Endoscopy
- Sonography
- Radiology: tomography (TDM, TEP), scintigraphy, MRI, PET scanning, etc.
- Personalized screening
- Markers:
- Protein and carbohydrate biomarkers in biological liquids (blood, pleura, peritonea, urinary)
- Immunopathological biomarkers
- Circulating nucleotides
- DNA, RNA, histone complex
- miRNAs
- Circular DNA
- Gene analysis and mutagenesis
- Heteroploid cells
- Circulating cancer cells
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Thyroid Cancer: New Advances from Diagnosis to Therapy (Deadline: 15 October 2023)
- Prevention, Diagnosis and Treatment of Oropharyngeal Cancers (Deadline: 20 October 2023)
- Gastrointestinal Cancers: Advances in Diagnostic, Prognostic, and Therapeutics (Deadline: 31 October 2023)
- Diagnosis and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (Deadline: 31 October 2023)
- Diagnosis of Melanoma and Non-melanoma Skin Cancer (Deadline: 5 November 2023)
- MRI in Prostate Cancer (Deadline: 15 November 2023)
- New Perspectives on Multiple Endocrine Neoplasia (Deadline: 15 November 2023)
- Advances in the Diagnosis, Prognosis and Treatment of Diffuse Large B-cell Lymphoma (Deadline: 15 November 2023)
- Noninvasive Diagnostic Imaging and Management of Skin Cancer (Deadline: 16 November 2023)
- Prevention and Screening in Gynaecological Cancers (Deadline: 20 November 2023)
- Current Challenge and Future Advances for Lung Cancer: Genetics, Instrumental Diagnosis and Treatment 2.0 (Deadline: 20 November 2023)
- Advances in the Diagnosis and Management of Uterine Sarcomas (Deadline: 30 November 2023)
- Magnetic Resonance Imaging in Renal Cell Carcinoma (Deadline: 30 November 2023)
- Advances in Salivary Gland Carcinoma (Deadline: 30 November 2023)
- Multiple Myeloma—Biology, Diagnosis, Treatment and Prognosis (Deadline: 30 November 2023)
- Advanced Research in Cancer Initiation and Early Detection (Deadline: 30 November 2023)
- Diagnosis of Hematologic Malignancies (Deadline: 1 December 2023)
- Differential Scanning Calorimetry and Related Thermal Analysis Techniques as Complementary Approaches for Cancer Diagnosis, Prognosis, Monitoring and Assessment of Treatment Response (Deadline: 1 December 2023)
- Gastrointestinal Malignancies in the Era of Precision Oncology: From Bench to Bedside and Back Again (Volume II) (Deadline: 15 December 2023)
- Causes, Consequences, Challenges and Opportunities of Tumor Angiogenesis (Deadline: 15 December 2023)
- Advances in Papillary Thyroid Cancer Research (Deadline: 15 December 2023)
- Innovations in Soft Tissue Sarcoma Diagnosis and Treatment (Deadline: 15 December 2023)
- The Applications of Radiomics in Precision Diagnosis and Treatment of Solid and Hematological Tumors (Deadline: 15 December 2023)
- Modern Evaluation and Treatment of Malignant Pancreatic, Liver and Biliary Tract Tumours (Deadline: 20 December 2023)
- Advanced Research in Pancreatic Ductal Adenocarcinoma (Deadline: 20 December 2023)
- Perihilar Cholangiocarcinoma (Deadline: 20 December 2023)
- New Insights in Neuroendocrine Neoplasms (NENs) and Thyroid Cancer: Focus on Basic, Translational, and Clinical Research (Deadline: 30 December 2023)
- Gynecologic Cancer: From Diagnosis to Treatment (Deadline: 30 December 2023)
- The Role of Endoscopy in Gastrointestinal Cancers (Deadline: 30 December 2023)
- Diagnosis, Treatment and Prognosis of Osteosarcoma (Deadline: 30 December 2023)
- Interventions Facilitating Patient-Mediated or Provider-Mediated Cancer Predisposition Cascade Genetic Screening (Deadline: 31 December 2023)
- Skin Cancer: Recent Advances in Diagnosis, Treatment, and Prevention (Deadline: 31 December 2023)
- New Insights into the Management of Intrahepatic Cholangiocarcinoma (Deadline: 31 December 2023)
- Decoding Cancer Signals Using Liquid Biopsy (Deadline: 31 December 2023)
- Early Detection and Surgery for Pancreatic Cancer (Deadline: 31 December 2023)
- Brain and Spinal Cord Tumors: Symptoms, Diagnosis, and Treatment (Deadline: 31 December 2023)
- Risk Factor Prediction, Diagnosis and Treatment of Breast Cancer (Deadline: 31 January 2024)
- Advanced Research in Multiple Myeloma, Volume II (Deadline: 31 January 2024)
- Screening and Early Detection of HPV-Related Cancers (Deadline: 1 February 2024)
- Cancer Genomics: Interpreting the Changing Landscape in Cancer Diagnosis and Treatment (Volume II) (Deadline: 1 February 2024)
- Current Updates and Future Directions in Neuroendocrine Neoplams (NENs): Understanding Biology, Diagnosis, Management and Research Efforts in NENs (Deadline: 20 February 2024)
- Research Advances in Genetic Variants Associated with Cancer (Deadline: 29 February 2024)
- Quantitative Imaging and Digital Pathology in Clinical Cancer Research (Deadline: 29 February 2024)
- Diagnosis and Staging of Gastroesophageal Cancer (Deadline: 29 February 2024)
- Diagnosis and Innovative Treatment of Localized Lung Cancer (Deadline: 10 March 2024)
- Recent Advances in Non-muscle Invasive Bladder Cancer (Deadline: 26 March 2024)
- Outcomes in Glioblastoma Patients: From Diagnosis to Palliation (Deadline: 31 March 2024)
- Artificial Intelligence in Cancer Screening (Deadline: 31 March 2024)
- Urologic Oncology in Focus: Insights, Trends, Evidence-Based Practices and Future Directions (Deadline: 31 March 2024)
- Advances in Tumor Vascular Imaging (Deadline: 31 March 2024)
- Breast Cancer Imaging: Current Trends and Future Direction (Deadline: 31 March 2024)
- Imaging and Liquid Biopsy Biomarkers for Cancer Diagnosis and Treatment (Deadline: 1 April 2024)
- Innovations in Diagnosis, Prognostic Evaluation, and Therapeutic Management of Gynecologic Tumors (Deadline: 15 April 2024)
- Multiple Myeloma: Recent Advances in Diagnosis, Analysis and Therapeutic Management (Deadline: 20 April 2024)
- Malignant Pleural Mesothelioma: Recent Advances in Diagnosis, Molecular Characterization, Predictive Markers and Treatment (Deadline: 30 April 2024)
- Innovations in Diagnosis and Treatment of Colon and Rectal Cancer: Preoperative Optimisation, Multidisciplinary Management, and Surgical Technology Advancement (Deadline: 30 April 2024)
- Breast Development and Cancer (Volume II) (Deadline: 30 April 2024)
- Novel Developments in Invasive Lobular Breast Cancer: Diagnosis, Prognosis and Therapy (Deadline: 30 April 2024)
- Unmet Need for Evidence on the Possible Role of Neoadjuvant Chemotherapy in Gynecologic Malignant Disease, Volume II (Deadline: 30 April 2024)
- Advances in the Diagnosis and Treatment of Genitourinary Cancers (Deadline: 10 May 2024)
- Histopathology and Diagnosis of Gastrointestinal Tumors (Deadline: 10 May 2024)
- MRI-Assisted Radiosurgery (MARS) (Deadline: 31 May 2024)
- Advances and Novel Multidisciplinary Strategies for Breast Cancer (Deadline: 15 July 2024)
- Radiology for Diagnosis and Treatment of Liver Cancer (Deadline: 20 July 2024)
- Precision Medicine Approaches for Prostate Cancer Diagnosis, Treatment, and Management (Deadline: 23 July 2024)
- New Insights in Mammographic Density in Breast Cancer Risk, Screening and Detection (Deadline: 31 July 2024)
- Testicular Lesions: Improving Characterization (Deadline: 31 August 2024)
- Towards a Personalized Medicine for the Diagnosis and Management of Gynecological Cancers (Deadline: 30 September 2024)
- Applications of Ex Vivo Microscopy in Cancer Detection and Diagnosis (Deadline: 31 October 2024)
- Cancer Causes and Control (Deadline: 31 December 2024)
- Applications of Different Knowledge Graphs and Large Language Models in Diagnosis Cancers (Deadline: 12 July 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Advances in Diagnostic and Interventional Radiology in Oncology
- Diagnosis, Treatment and Prevention of Gastrointestinal Cancer
- Diagnostic and Therapeutic Challenges in Patients with Primary or Secondary Brain Tumor
- Non-invasive Early Detection of Cancers
- Women’s Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer
